Prebiotics to fight diseases: Reality or fiction?

Phytotherapy Research

Volumn 27, Issue 10, 2013, Pages 1457-1473

  Di Bartolomeo, F ^a,b   Startek, J B ^a   Van Den Ende, W ^a  

^a LEUVEN FOOD SCIENCE AND NUTRITION RESEARCH CENTRE LFORCE   (Belgium)

^b University of Studies of Molise   (Italy)

Author keywords

colon cancer prevention; fructans; gastrointestinal diseases; low digestible carbohydrates; prebiotics

Indexed keywords

BETA GLUCAN; FRUCTAN; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; INULIN; OLIGOSACCHARIDE; PREBIOTIC AGENT; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESISTANT STARCH; SHORT CHAIN FATTY ACID; STARCH; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BIOLOGICAL ACTIVITY; CANCER PREVENTION; COLORECTAL CANCER; CROHN DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG MECHANISM; FUNCTIONAL FOOD; GASTROINTESTINAL DISEASE; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFECTION PREVENTION; INTESTINE FLORA; METABOLIC SYNDROME X; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

ANIMALIA; BACTERIA (MICROORGANISMS);

COLON CANCER PREVENTION; FRUCTANS; GASTROINTESTINAL DISEASES; LOW-DIGESTIBLE CARBOHYDRATES; PREBIOTICS;

ANIMALS; BACTERIA; COLORECTAL NEOPLASMS; DIABETES MELLITUS; FUNCTIONAL FOOD; GASTROINTESTINAL TRACT; HUMANS; INULIN; METABOLIC SYNDROME X; MICROBIOTA; OLIGOSACCHARIDES; PREBIOTICS;

EID: 84885669832     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4901     Document Type: Review

References (235)

1. Abrams SA, Griffin IJ, Hawthorne KM, et al., 2005. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 82: 471-476.
2. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K,. 2010. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 180: 1175-1183.
3. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P,. 1996. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 124: 825-831. (Pubitemid 26128413)
4. Alvaro A, Solà R, Rosales R, et al., 2008. Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life 60: 757-764.
5. Anderson PJ, Critchley JA, Chan JC, et al., 2001. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 25: 1782-1788. (Pubitemid 33131918)
6. Annison G, Topping DL,. 1994. Nutritional role of resistant starch: chemical structure vs physiological function. Annu Rev Nutr 14: 297-320. (Pubitemid 24261840)
7. Argenzio RA, Southworth M, Stevens CE,. 1974. Sites of organic acid production and absorption in the equine gastrointestinal tract. Am J Physiol 226: 1043-1050.
8. Arora T, Sharma R, Frost G,. 2011. Propionate. Anti-obesity and satiety enhancing factor? Appetite 56: 511-515.
9. Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C,. 2011. Bacteria and host interactions in the gut epithelial barrier. Nat Chem Biol 8: 36-45.
10. Barcelo A, Claustre J, Moro F, Chayvialle JA, Cuber JC, Plaisancié P,. 2000. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 46: 218-224. (Pubitemid 30305848)
11. Belenguer A, Duncan SH, Calder A, et al., 2006. Two routes of metabolic cross-feeding between Bifidobacterium Adolesentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72: 3593-3599. (Pubitemid 43728015)
12. Bernalier A, Dore J, Durand M,. 1999. Biochemistry of fermentation. In Colonic microbiota, nutrition and health, Gibson GR, Roberfroid MB, (eds). Kluwer academic publishers: London; 37-53.
13. Bertin Y, Boukhors K, Pradel N, Livrelli V, Martin C,. 2001. Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors. J Clin Microbiol 39: 3060-3065. (Pubitemid 32830294)
14. Bingham SA,. 1990. Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer. Proc Nutr Soc 49: 153-171.
15. Blaut M,. 2002. Relationship of prebiotics and food to intestinal microflora. Eur J Nutr 41: S11-S6.
16. Blottiére HM, Champ M, Hoebler C, Michel C, Cherbut C,. 1999. Production and digestive effects of short-chain fatty acids: from production towards gastrointestinal physiologicl effects. Science del Alimentes 19: 269-290. (Pubitemid 129509736)
17. Bolouri-Moghaddam M-R, Le Roy K, Xiang L, Rolland F, Van den Ende W,. 2010. Sugar signalling and antioxidant network connections in plant cells. FEBS J 277: 2022-2037.
18. Bouhnik Y, Raskine L, Simoneau G, et al., 2004. The capacity of nondigestible carbohydrates to stimulate fecal Bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80: 1658-1664. (Pubitemid 41103868)
19. Brady LJ, Gallaher DD, Busta FF,. 2000. The role of probiotic cultures in the prevention of colon cancer. J Nutr 130: 410S-414S. (Pubitemid 30073760)
20. Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA,. 2011. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr 51: 178-194.
21. Brown GD, Gordon S,. 2003. Fungal beta-glucans and mammalian immunity. Immunity 19: 311-315.
22. Brown I, Warhurst M, Arcot J, Playne M, Illman RJ, Topping DL,. 1997. Fecal numbers of Bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch. J Nutr 127: 1822-1827. (Pubitemid 27386410)
23. Brown IL, Wang X, Topping DL, Playne M J, Conway PL,. 1998. High amylose maize starch as a versatile prebiotic for use with probiotic bacteria. Food Aust 50: 603-610.
24. Bruce WR, Wolever TM, Giacca A,. 2000. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer 37: 19-26. (Pubitemid 30650662)
25. Buemann B, Toubro S, Raben A, Astrup A,. 1999. Human tolerance to a single, high dose of D-tagatose. Regul Toxicol Pharmacol 29: S66-70.
26. Cani PD, Joly E, Horsmans Y, Delzenne NM,. 2006. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60: 567-572. (Pubitemid 43922875)
27. Carabin IG, Flamm WG,. 1999. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul Toxicol Pharmacol 30: 268-282. (Pubitemid 30048997)
28. Casiraghi MC, Zanchi R, Canzi E, et al., 2011. Prebiotic potential and gastrointestinal effects of immature wheat grain (IWG) biscuits. Antonie Van Leeuwenhoek 99: 795-805.
29. Cassidy A, Bingham SA, Cummings JH,. 1994. Starch intake and colorectal cancer risk: an international comparison. Br J Cancer 69: 937-942. (Pubitemid 24140679)
30. Chambers TJ, Serafini EP,. 1985. The permeability of normal, adenomatous, ulcerative colitic and malignant large bowel epithelial cell membranes to inulin. Br J Exp Pathol 66: 309-315. (Pubitemid 15032568)
31. Chau I, Cunningham D,. 2006. Adjuvant therapy in colon cancer-what, when and how? Ann Oncol 17: 1347-1359. (Pubitemid 44400373)
32. Cheng HH, Lai MH,. 2000. Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. J Nutr 130: 1991-1995.
33. Cherbut C,. 2002. Inulin and oligofructose in the dietary fibre concept. Br J Nutr 87: S159-162. (Pubitemid 34685549)
34. Chien SY, Wu YC, Chung JG, et al., 2009. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol 28: 493-503.
35. Cho LW,. 2011. Metabolic syndrome. Singapore Med J 52: 779-785.
36. Choi YJ, Jeong YJ, Lee YJ, Kwon HM, Kang YH,. 2005. (-)Epigallocatechin gallate and quercetin enhance survival signaling in response to oxidant-induced human endothelial apoptosis. J Nutr 135: 707-713.
37. Chou CC, Yang JS, Lu HF, et al., 2010. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33: 1181-1191.
38. Chung J, Yoon YO, Lee JS, et al., 2011. Inulin induces dendritic cells apoptosis through the caspase-dependent pathway and mitochondrial dysfunction. Biol Pharm Bull 34: 495-500.
39. Conway PL,. 2001. Prebiotics and human health: The state of the art and future perspectives. Scand J Nutr 45: 13-21. (Pubitemid 32423683)
40. Correia MI, Nicoli JR,. 2006. The role of probiotics in gastrointestinal surgery. Curr Opin Clin Nutr Metab Care 9: 618-21. (Pubitemid 44258039)
41. Corrigan A, Horgan K, Clipson N, Murphy RA,. 2011. Effect of dietary supplementation with a Saccharomyces cerevisiae mannan oligosaccharide on the bacterial community structure of broiler cecal contents. Appl Env Microbiol 77: 6653-6662.
42. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT,. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227. (Pubitemid 17156038)
43. Daddaoua A, Puerta V, Requena P, et al., 2006. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J Nutr 136: 672-676. (Pubitemid 43363752)
44. De Gara L, de Pinto MC, Moliterni VMC, D'Egidio MG,. 2003. Redox regulation and storage processes during maturation in kernels of Triticum durum. J Exp Bot 54: 249-258. (Pubitemid 36101161)
45. De Leenheer L,. 1996. Production and use of inulin: industrial reality with a promising future. In Carbohydrates as organic raw materials III, Van Bekkum H, Röper H, Voragen F, (eds). V.C.H. Publishers: New York; 67-92.
46. De Vuyst L, Leroy F,. 2011. Cross-feeding between Bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int J Food Microbiol 149: 73-80.
47. Delzenne NM,. 2003. Oligosaccharides state of the art. Proc Nut Soc 62: 177-182.
48. Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K,. 2009. Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun 1: 123-135.
49. Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EB, Roberfroid MB,. 1999. Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 81: S1-S27.
50. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ,. 2004. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91: 915-923. (Pubitemid 38931455)
51. Ebersbach T, Andersen JB, Bergström A, Hutkins RW, Licht TR,. 2012. Xylo-oligosaccharides inhibit pathogen adhesion to enterocytes in vitro. Res Microbiol 163: 22-27.
52. Esawy MA, Ahmed EF, Helmy WA, Mansour NM, El-Senousy WM, El-Safty MM,. 2011. Production of levansucrase from novel honey Bacillus subtilis isolates capable of producing antiviral levans. Carbohydr Polymers 86: 823-830.
53. ESPGAN Committee on Nutrition. 1977. Guidelines on infant nutrition. I. Recommendations for the composition of an adapted formula. Acta Paediatr Scand Suppl 262: 1-20.
54. European Flair-Concerted Action on Resistant Starch (EURESTA). 1991. Physiological implications of the consumption of resistant starch in man. Flair Concerted Action No. 11, Newsl. III.
55. Farthing MJ,. 2004. Bugs and the gut: an unstable marriage. Best Pract Res Clin Gastroenterol 18: 233-9. (Pubitemid 38444128)
56. Fava F, Danese S,. 2010. Crohn's disease: bacterial clearance in Crohn's disease pathogenesis. Nat Rev Gastroenterol Hepatol 7: 126-128.
57. Femia AP, Salvadori M, Broekaert WF, et al., 2010. Arabinoxylan- oligosaccharides (AXOS) reduce preneoplastic lesions in the colon of rats treated with 1,2-dimethylhydrazine (DMH). Eur J Nutr 49: 127-132.
58. Fernandez ML,. 2001. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 12: 35-40.
59. Fernandez-Bañares F, Esteve-Pardo M, Humbert P, de Leon R, Llovet JM, Gassull MA,. 1991. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 101: 1453-1454.
60. Ferraresi R, Troiano L, Roat E, et al., 2005. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res 39: 1249-1258. (Pubitemid 41601428)
61. Flood MT, Auerbach MH, Craig SA,. 2004. A review of the clinical toleration studies of polydextrose in food. Food Chem Toxicol 42: 1531-1542. (Pubitemid 38844869)
62. Florent C, Flourie B, Leblond A, Rautureau M, Bernier JJ, Rambaud JC,. 1985. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 72: 608-613. (Pubitemid 15142071)
63. Fooks LJ, Gibson GR,. 2002. In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol Ecol 39: 67-75. (Pubitemid 34214794)
64. Forchielli ML, Walker WA,. 2005. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 93: S41-48. (Pubitemid 43073406)
65. Frank DN, Pace NR,. 2008. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 24: 4-10. (Pubitemid 350190890)
66. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR,. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci 104: 13780-5. (Pubitemid 350003397)
67. Fuentes-Zaragoza E, Sánchez-Zapata E, Sendra E, et al., 2011. Resistant starch as prebiotic. Starch-Stärke 63: 406-415.
68. Fukuda S, Toh H, Hase K, et al., 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547.
69. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM,. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197: 1107-1117. (Pubitemid 36570066)
70. Gantois I, Ducatelle R, Pasmans F, et al., 2006. Butyrate specifically down-regulates Salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 72: 946-949.
71. Gao Z, Yin J, Zhang J, et al., 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58: 1509-1517.
72. Ghandehari H, Smith PL, Ellens H, Yeh PY, Kopeček J,. 1997. Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium. JPET 280: 747-753. (Pubitemid 27171336)
73. Gibellini L, Pinti M, Nasi M, et al., 2010. Interfering with ROS metabolism in cancer cells: the potential role of quercetin. Cancers 2: 1288-1311.
74. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB,. 2004. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17: 259-275.
75. Gibson GR, Wang X,. 1994. Enrichment of Bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118: 121-127. (Pubitemid 124012137)
76. Gibson GR,. 2008. Prebiotics as gut microflora management tools. J Clin Gastroenterol 42: S75-99.
77. Gobinath D, Madhu AN, Prashant G, Srinivasan K, Prapulla SG,. 2010. Beneficial effect of xylo-oligosaccharides and fructo-oligosaccharides in streptozotocin-induced diabetic rats. Br J Nutr 104: 40-47.
78. Gomez E, Tuohy KM, Gibson GR, Klinder A, Costabile A,. 2009. In vitro evaluation of the fermentation properties and potential prebiotic activity of Agave fructans. J Appl Microbiol 108: 2114-2121.
79. Gopal PK, Sullivan PA, Smart BJ,. 2001. Utilization of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20. Int Dairy J 11: 19-25. (Pubitemid 32643881)
80. Govers MJ, Gannon NJ, Dunshea FR, Gibson PR, Muir JG,. 1999. Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs. Gut 45: 840-847.
81. Grabitske HA, Slavin JL,. 2008. Low-digestible carbohydrates in practice. J Am Diet Assoc 108: 1677-1681.
82. Grabitske HA, Slavin JL,. 2009. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 49: 327-360.
83. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F,. 2010. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev 23: 366-384.
84. Gustat J, Srinivasan SR, Elkasabany A, Berenson GS,. 2002. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study. J Clin Epidemiol 55: 997-1006. (Pubitemid 36018864)
85. Gyorgy P, Mello MI, Torres FE, Barness LA,. 1953. Growth promotion in rats by crude concentrates of the bifidus factor. Proc Soc Exp Biol Med 84: 464-7.
86. Gyorgy P, Norris RF, Rose CS,. 1954. Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys 48: 193-201.
87. Hague A, Paraskeva C,. 1995. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. Eur J Cancer Prev 4: 359-364.
88. Hancock JT, Desikan R, Neill SJ,. 2001. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 29: 345-350. (Pubitemid 32587530)
89. Hart AL, Lammers K, Brigidi P, et al., 2004. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53: 1602-1609. (Pubitemid 39434103)
90. Hausmann M, Kiessling S, Mestermann S, et al., 2002. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122: 1987-2000. (Pubitemid 34651441)
91. Hedin C, Whelan K, Lindsay JO,. 2007. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 66: 307-315. (Pubitemid 47076227)
92. Hendry GAF, Wallace RK,. 1993. The origin, distribution, and evolutionary significance of fructans. In Science and Technology of Fructans, Suzuki M, Chatterton NJ, (eds). CRC Press: Boca Raton, FL; 119-139.
93. Herre J, Gordon S, Brown GD,. 2004a. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol 40: 869-876. (Pubitemid 38032810)
94. Herre J, Willment JA, Gordon S, Brown GD,. 2004b. The role of Dectin-1 in antifungal immunity. Crit Rev Immunol 24: 193-203. (Pubitemid 39410865)
95. Herre J, Marshall AS, Caron E, et al., 2004c. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104: 4038-4045. (Pubitemid 39620154)
96. Hidaka H, Hirayama M, Tokunaga T, Eida T,. 1990. The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health. Adv Exp Med Biol 270: 105-117. (Pubitemid 20344325)
97. Ho Hoa TK,. 2000. Effects of yeast glucans on the gastrointestinal microflora of mice. PhD Thesis. University of New South Wales UNSW: Sydney, Australia.
98. Hoentjen F, Welling GW, Harmsen HJ, et al., 2005. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11: 977-985. (Pubitemid 41580011)
99. Holzapfel WH, Schillinger U,. 2002. Introduction to pre- and probiotics. Food Res Int 35: 109-116. (Pubitemid 34161549)
100. Huang Y, Suyemoto M, Garner CD, Cicconi KM, Altier C,. 2008. Formate acts as a diffusible signal to induce Salmonella invasion. J Bacteriol 190: 4233-4241. (Pubitemid 351812870)
101. Huazano-Garcia A, Garcia Perez MC, Garcia-Vieyra MI, Lopez MG,. 2009. In vivo prebiotic effect of branched fructans from Agave angustifolia (long DP) and Dasylirion sp (short DP). Ann Nutr & Metabol 55: 126.
102. Hughes R, Rowland IR,. 2001. Stimulation of apoptosis by two prebiotic chicoryfructans in the rat colon. Carcinogenesis 22: 43-47 (Pubitemid 32098142)
103. Imaizumi K, Hirata K, Yasni S, Sugano M,. 1992. Propionate enhances synthesis and secretion of bile acids in primary cultured rat hepatocytes via succinyl CoA. Biosci Biotechnol Biochem 56: 1894-1896.
104. Ito M, Deguchi Y, Miyamouri A, et al., 1990. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 3: 285-292.
105. Jenkins CLD, Lewis D, Bushell R, Belobrajdic DP, Bird AR,. 2011. Chain length of cereal fructans isolated from wheat stem and barley grain modulates in vitro fermentation. J Cereal Sci 53: 188-191.
106. Kaplan H, Hutkins RW,. 2000. Fermentation of fructooligosaccharides by lactic acid bacteria and Bifidobacteria. Appl Environ Microbiol 66: 2682-2684. (Pubitemid 30353985)
107. Kazak H, Toksoy Ã-ner E, Barbosa EM, Dekker RFH, Khaper N,. 2011. Biological significance of levan and glucan type exopolysaccharides in pancreatic cells. Poster presented at the International Heart Conference, Winnipeg.
108. Kelly G,. 2009. Inulin-type prebiotics: a review. (Part 2). Altern Med Rev 14: 36-55.
109. Kruh J, Tichonicky L, Defer N,. 1994. Effect of butyrate on gene expression. In Short chain Fatty Acids, Binder HJ, Cummings J, Soergel KH, (eds). Kluwer Academic Press: Lancaster; 135-147.
110. Kunz C, Rudloff S, Baier W, Klein N, Strobel S,. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20: 699-722.
111. Kuo PC, Liu HF, Chao JI,. 2004. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J Biol Chem 279: 55875-55885.
112. Laerke HN, Jensen BB, HÃ̧jsgaard S,. 2000. In vitro fermentation pattern of D-tagatose is affected by adaptation of the microbiota from the gastrointestinal tract of pigs. J Nutr 130: 1772-1779. (Pubitemid 30451066)
113. Lamprecht SA, Lipkin M,. 2003. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3: 601-614. (Pubitemid 37328832)
114. Lara-Villoslada F, Debras E, Nieto A, et al., 2006. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr 25: 477-488. (Pubitemid 43843021)
115. Larson CM, Bubrick MP, Jacobs DM, West MA,. 1995. Malignancy, mortality, and medicosurgical management of Clostridium septicum infection. Surgery 118: 592-597.
116. Lasseur B, Lothier J, Djoumad A, et al., 2006. Molecular and functional characterization of a cDNA encoding fructan:fructan 6 G-fructosyltransferase (6 G-FFT)/fructan:fructan 1-fructosyltransferase (1-FFT) from perennial ryegrass (Lolium perenne L.). J Exp Bot 57: 2719-2734. (Pubitemid 44290303)
117. Laurent C, Simoneau C, Marks L, et al., 1995. Effect of acetate and propionate on fasting hepatic glucose production in humans. Eur J Clin Nutr 49: 484-491.
118. Le Blay G, Michel C, Blottière HM, Cherbut C,. 1999. Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats. J Nutr 129: 2231-2235.
119. Le Poul E, Loison C, Struyf S, et al., 2003. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278: 25481-25489. (Pubitemid 36835299)
120. Lee JB, Miyake S, Umetsu R, Hayashi K, Chijimatsu T, Hayashi T,. 2012. Anti-influenza A virus effects of fructan from Welsh onion (Allium fistulosum L.). Food Chem 134: 2164-2168.
121. Leenen CH, Dieleman LA,. 2007. Inulin and oligofructose in chronic inflammatory bowel disease. J Nutr 137: 2572S-2575S. (Pubitemid 350058738)
122. Levison ME,. 1973. Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginosa and Enterobacteriaceae. Infect Immun 8: 30-35.
123. Levrat MA, Favier ML, Moundras C, Rémésy C, Demigné C, Morand C,. 1994. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr 124: 531-538. (Pubitemid 24139121)
124. Levrat-Verny MA, Behr S, Mustad V, Rémésy C, Demigné C,. 2000. Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption. J Nutr 130: 243-248. (Pubitemid 30073802)
125. Liévin-Le Moal V, Servin AL,. 2006. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19: 315-337.
126. Lim CC, Ferguson LR, Tannock GW,. 2005. Dietary fibres as "prebiotics": implications for colorectal cancer. Mol Nutr Food Res 49: 609-619. (Pubitemid 40853707)
127. Lindsay JO, Whelan K, Stagg AJ, et al., 2006. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55: 348-355. (Pubitemid 43268272)
128. Liong MT,. 2008. Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci 9: 854-863.
129. Lipkin M, Newmark H,. 1995. Calcium and the prevention of colon cancer. J Cell Biochem 22: 65-7.
130. Livesey G,. 2001. Tolerance of low-digestible carbohydrates: a general view. Br J Nutr 85: S7-16. (Pubitemid 32293770)
131. Lorraine LN, Suh NN,. 2003. Role of non-digestible carbohydrates in colon cancer protection. Nutr Food Sci 33: 28-3.
132. Ludwig DS, Pereira MA, Kroenke CH, et al., 1999. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 282: 1539-1546. (Pubitemid 29504047)
133. Lugli E, Troiano L, Ferraresi R, et al., 2005. Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A 68: 28-35. (Pubitemid 41572060)
134. Luo J, Van Yperselle M, Rizkalla SW, Rossi F, Bornet FR, Slama G,. 2000. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 130: 1572-1577. (Pubitemid 30340705)
135. Ly JD, Grubb DR, Lawen A,. 2003. The mitochondrial membrane potential (Delta Psim) in apoptosis; an update. Apoptosis 8: 115-128. (Pubitemid 36553052)
136. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT,. 2004. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38: 1690-1699. (Pubitemid 38781660)
137. Marteau P, Flourié B,. 2001. Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85: S17-21. (Pubitemid 32293771)
138. Martirosyan DM,. 2011. Functional Foods and Chronic Diseases: Science and Practice. Food Science Publisher: Richardson, TX.
139. Maslowski KM, Vieira AT, Ng A, et al., 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461: 1282-1286.
140. Mayfield ED, Bensadoun A, Johnson BC,. 1966. Acetate metabolism in ruminant tissues. J Nutr 89: 189-196.
141. Metodiewa D, Jaiswal AK, Cenas N, Dickancaité E, Segura-Aguilar J,. 1999. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26: 107-116. (Pubitemid 29001498)
142. Michel C, Kravtchenko TP, David A, Gueneau S, Kozlowski F, Cherbut C,. 1998. In vitro prebiotic effects of Acacia gums onto the human intestinal microbiota depends on both botanical origin and environmental pH. Anaerobe 4: 257-266. (Pubitemid 29353671)
143. Miller JB, McVeagh P,. 1999. Human milk oligosaccharides: 130 reasons to breast-feed. Br J Nutr 82: 333-335. (Pubitemid 29531261)
144. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS,. 2005. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135: 1304-1307. (Pubitemid 40638353)
145. Moshfegh AJ, Friday JE, Goldman JP, Ahuja JK,. 1999. Presence of inulin and oligofructose in the diets of Americans. J Nutr 129: 1407S-1411S. (Pubitemid 29302767)
146. Munjal U, Glei M, Pool-Zobel BL, Scharlau D,. 2009. Fermentation products of inulin-type fructans reduce proliferation and induce apoptosis in human colon tumour cells of different stages of carcinogenesis. Br J Nutr 102: 663-671.
147. Nakazawa I, Iwaizumi M,. 1989. A role of the cancer cell membrane fluidity in the cancer metastases: an ESR study. Tohoku J Exp Med 157: 193-198. (Pubitemid 19170530)
148. Neish AS, Gewirtz AT, Zeng H, et al., 2000. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289: 1560-1563.
149. Newburg DS, Ruiz-Palacios GM, Morrow AL,. 2005. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25: 37-58. (Pubitemid 41208993)
150. Newburg DS,. 1999. Human milk glycoconjugates that inhibit pathogens. Curr Med Chem 6: 117-127. (Pubitemid 29098655)
151. Niu G, Yin S, Xie S, et al., 2011. Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells. Acta Biochim Biophys Sin (Shanghai) 43: 30-37.
152. Noakes M, Clifton PM, Nestel PJ, Le Leu R, McIntosh G,. 1996. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr 64: 944-951. (Pubitemid 26392883)
153. North MJ,. 1983. Solute uptake by Dictyostelium discoideum and its inhibition. J Gen Microbiol 129: 1381-1386. (Pubitemid 13094101)
154. O'Hara AM, Shanahan F,. 2006. The gut flora as a forgotten organ. EMBO Rep 7: 688-93. (Pubitemid 43986264)
155. Ohtsuka K, Benno Y, Endo K, Ozawa O, Ueda H, Uchida T, Mitsuoka T,. 1989. Effects of 4'galactosyl-lactose intake on human fecal microflora. Bifidus 2: 143-149.
156. Olmstead S, Wolfson D, Meiss D, Ralston J,. 2008. Understanding Prebiotics. Technical summary.
157. Palframan RJ, Gibson GR, Rastall RA,. 2002. Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe 8: 287-292. (Pubitemid 36434183)
158. Payne ML, Craig WJ, Williams AC,. 1997. Sorbitol is a possible risk factor for diarrhea in young children. J Am Diet Assoc 97: 532-534. (Pubitemid 27194776)
159. Pelicano H, Carney D, Huang P,. 2004. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7: 97-110. (Pubitemid 38736063)
160. Perrin S, Warchol M, Grill JP, Schneider F,. 2001. Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium. J Appl Microbiol 90: 859-865. (Pubitemid 32500232)
161. Pool-Zobel BL, van Loo J, Rowland I, Roberfroid MB,. 2002. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br J Nutr 87: S273-281. (Pubitemid 34692568)
162. Pool-Zobel BL,. 2005. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 93: S73-90. (Pubitemid 43073411)
163. Raccuia SA, Melilli MG,. 2010. Seasonal dynamics of biomass, inulin, and water-soluble sugars in roots of Cynara cardunculus L. Field Crops Res 116: 147-153.
164. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R,. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241. (Pubitemid 38962578)
165. Raqib R, Sarker P, Bergman P, et al., 2006. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci 103: 9178-9183. (Pubitemid 43902552)
166. Roberfroid M, Gibson GR, Hoyles L, et al., 2010. Prebiotic effects: metabolic and health benefits. Br J Nutr 104: S1-63.
167. Roberfroid MB, Van Loo JA, Gibson GR,. 1998. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128: 11-9. (Pubitemid 28087170)
168. Roberfroid MB,. 2007a. Prebiotics: the concept revisited. J Nutr 3: S830-S837.
169. Roberfroid MB,. 2007b. Inulin-type fructans: functional food ingredients. J Nutr 137: S 2493-S2502.
170. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN,. 2005. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal
171. Roderick I, Mackie H, Gaskins R,. 1999. Gastrointestinal microbial ecology. Science & Medicine 6: 18.
172. Rodríguez-Cabezas ME, Camuesco D, Arribas B, et al., 2010. The combination of fructooligosaccharides and resistant starch show prebiotic additive effects in rats. Clin Nutr 29: 832-839.
173. Rogers NC, Slack EC, Edwards AD, et al., 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 507-517. (Pubitemid 40545115)
174. Rowland IR, Rumney CJ, Coutts JT, Lievense LC,. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19: 281-285. (Pubitemid 28375422)
175. Rushton HA, Slavin JL,. 2007. Low-digestible carbohydrates and bowel function. FASEB J 21: A1101.
176. Russo P, Lopez P, Capozzi V, et al., 2012. Beta-glucans improve growth, viability and colonization of probiotic microorganisms. Int J Mol Sci 13: 6026-6039.
177. Ryan-Harshman M, Aldoori W,. 2007. Diet and colorectal cancer: Review of the evidence. Can Fam Physician 53: 1913-1920. (Pubitemid 351198327)
178. Sabater-Molina M, Larqué E, Torrella F, Zamora S,. 2009. Dietary fructooligosaccharides and potential benefits on health. J Physiol Biochem 65: 315-328.
179. Sakaguchi E, Sakoda C, Toramaru Y,. 1998. Caecal fermentation and energy accumulation in the rat fed on indigestible oligosaccharides. Br J Nutr 80: 469-476. (Pubitemid 28528839)
180. Sartor RB,. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633. (Pubitemid 38649878)
181. Schaaf RE, Jacobs N, Kelvin FM, Gallis HA, Akwari O, Thompson WM,. 1980. Clostridium septicum infection associated with colonic carcinoma and hematologic abnormality. Radiology 137: 625-627. (Pubitemid 11203690)
182. Scheppach W, Luehrs H, Menzel T,. 2001. Beneficial health effects of low-digestible carbohydrate consumption. Br J Nutr 85: S23-S30. (Pubitemid 32293772)
183. Scholz-Ahrens KE, Schaafsma G, van den Heuvel EG, Schrezenmeir J,. 2001. Effects of prebiotics on mineral metabolism. Am J Clin Nutr 73: S459-S464.
184. Sekirov I, Russell SL, Antunes LC, Finlay BB,. 2010. Gut microbiota in health and disease. Physiol Rev 90: 859-904.
185. Shanahan F,. 2002. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 16: 915-31.
186. Shanahan F,. 2004. Probiotics in inflammatory bowel disease-therapeutic rationale and role. Adv Drug Deliv Rev 56: 809-818. (Pubitemid 38520101)
187. Sheu WH, Lee IT, Chen W, Chan YC,. 2008. Effects of xylooligosaccharides in type 2 diabetes mellitus. J Nutr Sci Vitaminol (Tokyo) 54: 396-401.
188. Shimizu K, Watanuki M, Tanaka R,. 2001. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J Appl Microbiol 91: 985-996. (Pubitemid 33132065)
189. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW,. 2006. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 74: 6920-6928. (Pubitemid 44913167)
190. Sok M, Sentjurc M, Schara M, Stare J, Rott T,. 2002. Cell membrane fluidity and prognosis of lung cancer. Ann Thorac Surg 73: 1567-1571. (Pubitemid 34596594)
191. Spiller R,. 2008. Probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 28: 385-396. (Pubitemid 352033280)
192. Stoyanova S, Geuns J, Hideg E, Van den Ende W,. 2011. The food additives inulin and stevioside counteract oxidative stress. Int J Food Sci Nutr 62: 207-214.
193. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP,. 2005. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 8: 1131-40. (Pubitemid 40352998)
194. Symons P, Jones MP, Kellow JE,. 1992. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 27: 940-944.
195. Szatrowski TP, Nathan CF,. 1991. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798.
196. Taylor PR, Brown GD, Reid DM, et al., 2002. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 169: 3876-3882.
197. Tamura K, Kawakami A, Sanada Y, Tase K, Komatsu T, Yoshida M,. 2009. Cloning and functional analysis of a fructosyltransferase cDNA for synthesis of highly polymerized levans in timothy (Phleum pratense L.). J Exp Bot 60: 893-905.
198. Thompson IJ, Oyston PC, Williamson DE,. 2010. Potential of the beta-glucans to enhance innate resistance to biological agents. Expert Rev Anti Infect Ther 8: 339-352.
199. Tomomatsu H,. 1994. Healthy effects of oligosaccharides. Food Technol 10: 61-65.
200. Topping DL, Clifton PM,. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81: 1031-1064. (Pubitemid 32611227)
201. Topping DL, Warhurst M, Illman RJ, Brown IL, Playne MJ, Bird AR,. 1997. A high amylose (amylomaize) starch and fructooligosaccharide increase fecal excretion of Bifidobacteria in pigs fed live Bifidobacterium longum. Proc Nutr Soc 21: 134.
202. Toscani A, Soprano DR, Soprano KJ,. 1988. Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res 3: 223-238. (Pubitemid 19092747)
203. Toyokuni S, Okamoto K, Yodoi J, Hiai H,. 1995. Persistent oxidative stress in cancer. FEBS Lett 358: 1-3.
204. Trautwein EA, Rieckhoff D, Erbersdobler HF,. 1998. Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J Nutr 128: 1937-1943. (Pubitemid 28509858)
205. Troiano L, Ferraresi R, Lugli E, et al., 2007. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry. Nat Protoc 2: 2719-2727.
206. Tsoni SV, Brown GD,. 2008. Beta-Glucans and dectin-1. Ann N Y Acad Sci 1143: 45-60.
207. Vaidya RH, Sheth MK,. 2010. Processing and storage of Indian cereal and cereal products alters its resistant starch content. J Food Sci Technol 48: 622-627.
208. Valera I, Fernández N, Trinidad AG, et al., 2008. Costimulation of dectin-1 and DC-SIGN triggers the arachidonic acid cascade in human monocyte-derived dendritic cells. J Immunol 180: 5727-5736.
209. Vamanu E, Vamanu A,. 2010. Viability of the Lactobacillus rhamnosus IL1 strain in simulated gastrointestinal conditions. Int J Pharmacol 6: 732-737.
210. Van den Ende W, Michiels A, De Roover J, Van Laere A, 2002. Fructan biosynthetic and breakdown enzymes in dicots evolved from different invertases. Expression of fructan genes throughout chicory development. The Scientific World J 2: 1273-1287.
211. Van den Ende W, Peshev D, De Gara L,. 2011. Disease prevention by natural antioxidants and prebiotics acting as ROS scavengers in the gastrointestinal tract. Trends Food Sci Tech 22: 689-697.
212. Van den Heuvel EG, Wils D, Pasman WJ, Bakker M, Saniez MH, Kardinaal AF,. 2004. Short-term digestive tolerance of different doses of NUTRIOSE FB, a food dextrin, in adult men. Eur J Clin Nutr 58: 1046-1055. (Pubitemid 39077151)
213. Van Loo J, Coussement P, de Leenheer L, Hoebregs H, Smits G,. 1995. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr 35: 525-552.
214. Venter CS, Vorster HH, Cummings JH,. 1990. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol 85: 549-553. (Pubitemid 20164311)
215. Vester Boler BM, Fahey GC Jr., 2012. Prebiotics of plant and microbial origin. In Direct Fed Microbials and Prebiotics for Animals: Science and Mechanisms of Action, Callaway TR, Ricke SC, (eds). Springer: New York, NY; 12-26.
216. Videla S, Vilaseca J, Antolín M, et al., 2001. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96: 1486-1493. (Pubitemid 32455079)
217. Vogt JA, Ishii-Schrade KB, Pencharz PB, Jones PJ, Wolever TM,. 2006. L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. J Nutr 136: 2160-2166. (Pubitemid 44156819)
218. Vogt JA, Ishii-Schrade KB, Pencharz PB, Wolever TM,. 2004. L-Rhamnose increases serum propionate after long-term supplementation, but lactulose does not raise serum acetate. Am J Clin Nutr 80: 1254-1261. (Pubitemid 41350686)
219. Von Figura K, Kresse H,. 1974. Inhibition of Pinocytosis by Cytochalasin B. Eur J Biochem 48: 357-363.
220. Wang P, Zhang K, Zhang Q, Mei J, Chen CJ, Feng ZZ, Yu DH,. 2012. Effects of quercetin on the apoptosis of the human gastric carcinoma cells. Toxicol In Vitro 26: 221-228.
221. Wang PH,. 2005. Altered Glycosylation in Cancer: Sialic Acids and Sialyltransferases. J Cancer Mol 1: 73-81.
222. Wang X, Brown IL, Evans AJ, Conway PL,. 1999a. The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse intestinal tract. J Appl Microbiol 87: 631-639. (Pubitemid 30038463)
223. Wang X, Conway PL, Brown IL, Evans AJ,. 1999b. In vitro utilization of amylopectin and high-amylose maize (amylomaize) starch granules by human colonic bacteria. Appl Environ Microbiol 65: 4848-4854.
224. Wang Y, Devkota S, Musch MW, et al., 2010. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One 5: e13607.
225. Weickert MO, Möhlig M, Schöfl C, et al., 2006. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 29: 775-780. (Pubitemid 44115293)
226. Weidmann P, Boehlen LM, de Courten M,. 1993. Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J 125: 1498-1513. (Pubitemid 23138406)
227. World Health Organization. 1948. Preamble of the Constitution of the World Health Organization as adopted by the International Health Conference. Official Records of the WHO 2: 100.
228. World Health Organization [Internet]. 2012. Cancer Fact sheet N°297 Available from: http://www.who.int/mediacentre/factsheets/fs297/en/
229. Wright RS, Anderson JW, Bridges SR,. 1990. Propionate inhibits hepatocyte lipid synthesis. Proc Soc Exp Biol Med 195: 26-29. (Pubitemid 20337239)
230. Yang JH, Hsia TC, Kuo HM, et al., 2006. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 34: 296-304.
231. Yazawa K, Imai K, Tamura Z,. 1978. Oligosaccharides and polysaccharides specifically utilizable by Bifidobacteria. Chem Pharm Bull(Tokyo) 26: 3306-11. (Pubitemid 9074851)
232. Yeo SK, Liong MT,. 2010. Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics. Int J Food Sci Nutr 61: 161-181.
233. Yeo SK, Ooi LG, Lim TJ, Liong MT,. 2009. Antihypertensive properties of plant-based prebiotics. Int J Mol Sci 10: 3517-3530.
234. Yun H, Lee JH, Park CE, et al., 2009. Inulin increases glucose transport in C2C12 myotubes and HepG2 cells via activation of AMP-activated protein kinase and phosphatidylinositol 3-kinase pathways. J Med Food 12: 1023-1028.
235. Zemel MB,. 2001. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 20: S428-S435.